MedTrace Logo

Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181

NCT01446770 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-03-13

No results posted yet for this study

Summary

The objective of the study is to evaluate the initial safety and efficacy of MF-4181, a hydrogel scaffold, in the reduction of the volume, appearance, and/or symptoms associated with keloid scarring in subjects undergoing surgical revision of keloid scars.

Conditions

  • Keloid

Interventions

DEVICE

Hydrogel scaffold (MF-4181)

Following surgical removal of the ear keloid, the incision will be treated with MF-4181.

Sponsors & Collaborators

  • Halscion, Inc.

    lead INDUSTRY

Principal Investigators

  • Srikanth Garikaparthi, MD · Princess Margaret Hospital, Canada

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • The Bahamas

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01446770 on ClinicalTrials.gov